<?xml version='1.0' encoding='utf-8'?>
<document id="10959522"><sentence text="A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report." /><sentence text="Gemfibrozil-statin combination therapy is a well-known risk factor for myopathy and rhabdomyolysis"><entity charOffset="0-11" id="DDI-PubMed.10959522.s2.e0" text="Gemfibrozil" /></sentence><sentence text=" Cerivastatin is a currently available statin with dual elimination; it is therefore expected to cause less drug-drug interaction"><entity charOffset="1-13" id="DDI-PubMed.10959522.s3.e0" text="Cerivastatin" /></sentence><sentence text=" This case is the second reported case with severe rhabdomyolysis caused by cerivastatin-gemfibrozil combination" /><sentence text=" Moreover, in this case, the rhabdomyolysis was more severe and caused severe renal failure and death" /><sentence text=" The authors discuss how these drugs cause rhabdomyolysis and how rhabdomyolysis can cause renal failure" /><sentence text="" /></document>